Non small cell lung cancer ultrasound: Difference between revisions
No edit summary |
Ahmed Younes (talk | contribs) |
||
| Line 46: | Line 46: | ||
*Accurate discrimination of primary hilar tumors and involved lymph nodes is important | *Accurate discrimination of primary hilar tumors and involved lymph nodes is important | ||
|} | |} | ||
==References== | ==References== | ||
Revision as of 20:11, 27 March 2018
|
Non Small Cell Lung Cancer Microchapters |
|
Differentiating Non Small Cell Lung Cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non small cell lung cancer ultrasound On the Web |
|
American Roentgen Ray Society Images of Non small cell lung cancer ultrasound |
|
Directions to Hospitals Treating Non small cell carcinoma of the lung |
|
Risk calculators and risk factors for Non small cell lung cancer ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
On endobronchial and endoscopic ultrasound, characteristic findings of non-small cell lung cancer include enlarged lymph nodes and local invasion to adjacent bronchial structures and mediastinum. Endobronchial ultrasound is a first-line diagnostic modality for mediastinal staging.
Ultrasound
Endobronchial ultrasound is a first-line diagnostic modality for mediastinal staging.The sensitivity of endobronchial ultrasound is 90% and specificity is 97%.[1][2]
- Indications of endobronchial ultrasound include:
- Evaluation of lymph nodes and other structures in the mediastinum
- Mediastinal invasion staging
- Determination of management strategy
- Real time evaluation of structures
- On ultrasound (endobronchial ultrasound), characteristic findings of non-small cell lung cancer include:
- Enlarged lymph nodes
- Local invasion of adjacent bronchial structures and mediastinum
- The table below summarizes the advantages and disadvantages of both ultrasound modalities, for the diagnostic assessment of non-small cell lung cancer.
Procedure Advantages Disadvantages Endobronchial ultrasound (EBUS) - Direct visualization of lymph node stations.
- Complements endoscopic ultrasound: covers lymph node stations 2R and 4R which are difficult to access by endoscopic ultrasound
- Lower false-negative rate than with blind transbronchial fine needle aspiration and fewer complications
- More invasive than endoscopic ultrasound, few practitioners, but rapidly growing in popularity
Endoscopic ultrasound (EUS) - Least invasive modality
- Uses the esophagus to access mediastinal lymph nodes
- Excellent for staging lymph nodes
- Useful for station 2L and 4L, L adrenal, celiac lymph node
- Cannot reliably access right sided paratracheal lymph node stations 2 R and 4R
- Accurate discrimination of primary hilar tumors and involved lymph nodes is important
References
- ↑ Kinsey CM, Arenberg DA (2014). "Endobronchial ultrasound-guided transbronchial needle aspiration for non-small cell lung cancer staging". Am. J. Respir. Crit. Care Med. 189 (6): 640–9. doi:10.1164/rccm.201311-2007CI. PMID 24484269.
- ↑ Tests for non-small cell lung cancer. American Cancer Society. http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-diagnosis Accessed on February 25, 2016